National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 38075-38076 [2012-15588]
Download as PDF
Federal Register / Vol. 77, No. 123 / Tuesday, June 26, 2012 / Notices
Dated: June 20, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
rmajette on DSK2TPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Immunology.
Date: July 12–13, 2012.
Time: 8 a.m. to 10 a.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Long Beach Hotel, 111
East Ocean Boulevard, Long Beach, CA
90802.
Contact Person: Jin Huang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4199,
MSC 7812, Bethesda, MD 20892, 301–435–
1230, jh377p@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Review of
Immunology AREA Grant Applications.
Date: July 13, 2012.
Time: 10 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Long Beach Hotel, 111
East Ocean Boulevard, Long Beach, CA
90802.
Contact Person: Jin Huang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4095G,
MSC 7812, Bethesda, MD 20892, 301–435–
1230, jh377p@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
VerDate Mar<15>2010
15:33 Jun 25, 2012
Jkt 226001
[FR Doc. 2012–15591 Filed 6–25–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; ‘‘Limited CompetitionWomen’s Interagency HIV Study (WIHS–V)’’.
Date: July 16–17, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Roberta Binder, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
Room 3130, Bethesda, MD 20892–7616, 301–
496–7966, rbinder@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 20, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–15590 Filed 6–25–12; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
38075
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Type 1 Diabetes
Mouse Resource.
Date: July 23, 2012.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Robert Wellner, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 706,, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–4721,
rw175w@nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; IBD Genetics
Consortium Data Coordinating Center.
Date: July 24, 2012.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Lakshmanan Sankaran,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 755, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7799, ls38z@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
E:\FR\FM\26JNN1.SGM
26JNN1
38076
Federal Register / Vol. 77, No. 123 / Tuesday, June 26, 2012 / Notices
Dated: June 20, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
The accreditation and approval
of SGS North America, Inc., as
commercial gauger and laboratory
became effective on September 29, 2011.
The next triennial inspection date will
be scheduled for September 2014.
FOR FURTHER INFORMATION CONTACT:
Stephen Cassata, Laboratories and
Scientific Services, U.S. Customs and
Border Protection, 1300 Pennsylvania
Avenue NW., Suite 1500N, Washington,
DC 20229, 202–344–1060.
DATES:
[FR Doc. 2012–15588 Filed 6–25–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Accreditation and Approval of SGS
North America, Inc., as a Commercial
Gauger and Laboratory
Dated: June 18, 2012.
Ira S. Reese,
Executive Director.
[FR Doc. 2012–15514 Filed 6–25–12; 8:45 am]
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of accreditation and
approval of SGS North America, Inc., as
a commercial gauger and laboratory.
BILLING CODE 9111–14–P
Notice is hereby given that,
pursuant to 19 CFR 151.12 and 19 CFR
151.13, SGS North America, Inc., 3735
W. Airline Hwy., Reserve, LA 70084,
has been approved to gauge and
accredited to test petroleum and
petroleum products, organic chemicals
and vegetable oils for customs purposes,
in accordance with the provisions of 19
CFR 151.12 and 19 CFR 151.13. Anyone
wishing to employ this entity to conduct
laboratory analyses and gauger services
should request and receive written
assurances from the entity that it is
accredited or approved by the U.S.
Customs and Border Protection to
conduct the specific test or gauger
service requested. Alternatively,
inquires regarding the specific test or
gauger service this entity is accredited
or approved to perform may be directed
to the U.S. Customs and Border
Protection by calling (202) 344–1060.
The inquiry may also be sent to
cbp.labhq@dhs.gov. Please reference the
Web site listed below for a complete
listing of CBP approved gaugers and
accredited laboratories. https://cbp.gov/
linkhandler/cgov/trade/automated/
labs_scientific_svcs/
commercial_gaugers/gaulist.ctt/
gaulist.pdf.
Quarterly IRS Interest Rates Used in
Calculating Interest on Overdue
Accounts and Refunds on Customs
Duties
AGENCY:
SUMMARY:
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Customs and Border Protection,
Department of Homeland Security.
ACTION: General notice.
AGENCY:
This notice advises the public
of the quarterly Internal Revenue
Service interest rates used to calculate
interest on overdue accounts
(underpayments) and refunds
(overpayments) of customs duties. For
the calendar quarter beginning July 1,
2012, the interest rates for overpayments
will be 2 percent for corporations and 3
percent for non-corporations, and the
interest rate for underpayments will be
3 percent for both corporations and noncorporations. This notice is published
for the convenience of the importing
public and Customs and Border
Protection personnel.
DATES: Effective Date: July 1, 2012.
FOR FURTHER INFORMATION CONTACT: Ron
Wyman, Revenue Division, Collection
and Refunds Branch, 6650 Telecom
Drive, Suite #100, Indianapolis, Indiana
46278; telephone (317) 614–4516.
SUPPLEMENTARY INFORMATION:
SUMMARY:
rmajette on DSK2TPTVN1PROD with NOTICES
Beginning date
070174
070175
020176
020178
020180
020182
010183
070183
VerDate Mar<15>2010
15:33 Jun 25, 2012
Jkt 226001
063075
013176
013178
013180
013182
123182
063083
123184
PO 00000
Pursuant to 19 U.S.C. 1505 and
Treasury Decision 85–93, published in
the Federal Register on May 29, 1985
(50 FR 21832), the interest rate paid on
applicable overpayments or
underpayments of customs duties must
be in accordance with the Internal
Revenue Code rate established under 26
U.S.C. 6621 and 6622. Section 6621 was
amended (at paragraph (a)(1)(B) by the
Internal Revenue Service Restructuring
and Reform Act of 1998, Pub. L. 105–
206, 112 Stat. 685) to provide different
interest rates applicable to
overpayments: one for corporations and
one for non-corporations.
The interest rates are based on the
Federal short-term rate and determined
by the Internal Revenue Service (IRS) on
behalf of the Secretary of the Treasury
on a quarterly basis. The rates effective
for a quarter are determined during the
first-month period of the previous
quarter.
In Revenue Ruling 2012–16, the IRS
determined the rates of interest for the
calendar quarter beginning July 1, 2012,
and ending on September 30, 2012. The
interest rate paid to the Treasury for
underpayments will be the Federal
short-term rate (1%) plus two
percentage points (2%) for a total of
three percent (3%) for both corporations
and non-corporations. For corporate
overpayments, the rate is the Federal
short-term rate (1%) plus one
percentage point (1%) for a total of two
percent (2%). For overpayments made
by non-corporations, the rate is the
Federal short-term rate (1%) plus two
percentage points (2%) for a total of
three percent (3%). These interest rates
are subject to change for the calendar
quarter beginning October 1, 2012, and
ending December 31, 2012.
For the convenience of the importing
public and Customs and Border
Protection personnel the following list
of IRS interest rates used, covering the
period from before July of 1974 to date,
to calculate interest on overdue
accounts and refunds of customs duties,
is published in summary format.
Under-payments
(percent)
Ending date
................................................................
................................................................
................................................................
................................................................
................................................................
................................................................
................................................................
................................................................
Background
...............................................................
...............................................................
...............................................................
...............................................................
...............................................................
...............................................................
...............................................................
...............................................................
Frm 00044
Fmt 4703
Sfmt 4703
E:\FR\FM\26JNN1.SGM
6
9
7
6
12
20
16
11
26JNN1
Over-payments
(percent)
6
9
7
6
12
20
16
11
Corporate
overpayments
(Eff. 1–1–99)
(percent)
........................
........................
........................
........................
........................
........................
........................
........................
Agencies
[Federal Register Volume 77, Number 123 (Tuesday, June 26, 2012)]
[Notices]
[Pages 38075-38076]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-15588]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Type 1 Diabetes Mouse
Resource.
Date: July 23, 2012.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Robert Wellner, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 706,, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-
594-4721, rw175w@nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; IBD Genetics Consortium
Data Coordinating Center.
Date: July 24, 2012.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Lakshmanan Sankaran, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 755, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-7799, ls38z@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
[[Page 38076]]
Dated: June 20, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-15588 Filed 6-25-12; 8:45 am]
BILLING CODE 4140-01-P